INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $207,000 | -94.0% | 12,691 | -91.0% | 0.00% | -83.3% |
Q4 2020 | $3,463,000 | +828.4% | 140,300 | +1458.9% | 0.01% | +500.0% |
Q3 2020 | $373,000 | -56.7% | 9,000 | -50.0% | 0.00% | -66.7% |
Q2 2020 | $862,000 | -82.6% | 18,000 | -55.0% | 0.00% | -83.3% |
Q4 2019 | $4,957,000 | +151.0% | 40,000 | +33.3% | 0.02% | +157.1% |
Q3 2019 | $1,975,000 | -24.3% | 30,000 | -77.4% | 0.01% | +16.7% |
Q2 2019 | $2,610,000 | +736.5% | 133,000 | +4650.0% | 0.01% | +500.0% |
Q1 2019 | $312,000 | +15500.0% | 2,800 | +17400.0% | 0.00% | – |
Q4 2018 | $2,000 | -99.2% | 16 | -99.1% | 0.00% | -100.0% |
Q3 2018 | $236,000 | -35.5% | 1,865 | -38.3% | 0.00% | 0.0% |
Q2 2017 | $366,000 | -4.7% | 3,023 | +11.8% | 0.00% | 0.0% |
Q2 2016 | $384,000 | -96.8% | 2,704 | -94.6% | 0.00% | -96.9% |
Q3 2014 | $11,955,000 | +18.8% | 50,216 | +20.3% | 0.03% | +966.7% |
Q2 2014 | $10,064,000 | +3084.8% | 41,739 | +4275.2% | 0.00% | – |
Q1 2014 | $316,000 | -91.3% | 954 | -98.2% | 0.00% | -100.0% |
Q4 2013 | $3,632,000 | +359.2% | 53,202 | +198.4% | 0.02% | +183.3% |
Q2 2013 | $791,000 | +95.3% | 17,832 | +65.3% | 0.01% | +50.0% |
Q1 2013 | $405,000 | -25.8% | 10,790 | -32.6% | 0.00% | -33.3% |
Q4 2012 | $546,000 | – | 16,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |